Anebulo Pharmaceuticals Inc (ANEB) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Anebulo Pharmaceuticals Inc   (NASDAQ: ANEB)


Anebulo Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Anebulo Pharmaceuticals Inc's ROI in the second quarter of 2026?
Anebulo Pharmaceuticals Inc recorded a cumulative net loss of $-8 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -74.58%.

Within the Healthcare sector 550 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2025 quarter, so far to 3433, from total ROI ranking in the first quarter of 2026 at 3579.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter		 (Mar 31 2025)
III. Quarter		 (Dec 31 2024)
II. Quarter
Y / Y Investment Change TTM 50.8 % 153.02 % 63.16 % 4.76 % -33.47 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 8 10 12 13 16
Return On Investment (TTM) -74.58 % -66.61 % -78.15 % -85.81 % -108.07 %
ANEB's Overall Ranking # 3433 # 3579 # 3524 # 3831 # 4068
Seq. Investment Change TTM -15.59 % 16.74 % 21.16 % 26.31 % 41.62 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -8 -8 -8 -8 -8

ANEB Company Profile >> Back to ANEB Roi Comparisons >> See Annual ANEB Return On Investment



Return On Investment ANEB's Ranking
Within: No.
Industry # 241
Sector # 551
Overall # 3433

Return On Investment Statistics
High Average Low
-31.24 %
-81.29 %
-158.14 %
(Sep 30 2021)   (Sep 30 2024)







Financial Statements
Anebulo Pharmaceuticals Inc's II. Quarter Investments $ 8 Millions ANEB's Balance sheet
Anebulo Pharmaceuticals Inc's II. Quarter Income $ -2 Millions Quarterly ANEB's Income Statement
ANEB's Income by Division See ANEB's Income by Division


ANEB Annual Return On Investment (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021
Total Investments in Millions 12 4 12 15 21
Y / Y Investment Growth 198.19 % -65.1 % -22.54 % -29.63 % -
Net Income in Millions -8 -8 -12 -7 -30
Y / Y Net Income Growth - - - - -
Annual Return On Investment -69.86 % -201.36 % -100.53 % -45.3 % -141.29 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ANEB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ANEB's Competitors
Subscribers only: Roi for Anebulo Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ANEB's Customers

Other Ratios
ANEB's Roa ANEB's Inventory Turnover Ratio ANEB's Growth Rates ANEB's Dividend Statistics
ANEB's Profitability Ratios ANEB's Asset Turnover Ratio ANEB's Dividend Growth
ANEB's Roe ANEB's Valuation Ratios ANEB's Financial Strength Ratios ANEB's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-09-12T06:25:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.